Cohort study

11,445views

Cohort study

Watch later

Watch later

Approach to hypertension: Clinical sciences
Chest X-ray interpretation: Clinical sciences
Acute mesenteric ischemia: Clinical sciences
Aortic dissection: Clinical sciences
Cardiac tamponade: Clinical sciences
Congestive heart failure: Clinical sciences
Hypovolemic shock: Clinical sciences
Infectious endocarditis: Clinical sciences
Mitral stenosis: Clinical sciences
Pericarditis: Clinical sciences
Peripheral arterial disease and ulcers: Clinical sciences
Right heart failure: Clinical sciences
Temporal arteritis: Clinical sciences
Valvular insufficiency (regurgitation): Clinical sciences
Approach to hyperthyroidism and thyrotoxicosis: Clinical sciences
Approach to hypothyroidism: Clinical sciences
Approach to hypoglycemia: Clinical sciences
Acute pancreatitis: Clinical sciences
Cushing syndrome and Cushing disease: Clinical sciences
Adrenal insufficiency: Clinical sciences
Diabetes mellitus (Type 1): Clinical sciences
Diabetes mellitus (Type 2): Clinical sciences
Hyperosmolar hyperglycemic state: Clinical sciences
Graves disease: Clinical Sciences
Diabetic ketoacidosis: Clinical sciences
Hashimoto thyroiditis: Clinical sciences
Hyperparathyroidism: Clinical sciences
Primary aldosteronism (hyperaldosteronism): Clinical sciences
Syndrome of inappropriate antidiuretic hormone secretion: Clinical sciences
Approach to periumbilical and lower abdominal pain: Clinical sciences
Acetaminophen (Paracetamol) toxicity: Clinical sciences
Appendicitis: Clinical sciences
Cholecystitis: Clinical sciences
Choledocholithiasis and cholangitis: Clinical sciences
Diverticulitis: Clinical sciences
Hepatic encephalopathy: Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Ileus: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Large bowel obstruction: Clinical sciences
Peptic ulcer disease: Clinical sciences
Small bowel obstruction: Clinical sciences
Approach to bleeding disorders (coagulopathy): Clinical sciences
Approach to bleeding disorders (thrombocytopenia): Clinical sciences
Approach to bleeding disorders (platelet dysfunction): Clinical sciences
Approach to hypercoagulable disorders: Clinical sciences
Approach to leukemia: Clinical sciences
Iron deficiency anemia: Clinical sciences
Sickle cell disease: Clinical sciences
Vitamin B12 deficiency: Clinical sciences
Basal cell carcinoma: Clinical sciences
Burns: Clinical sciences
Lyme disease: Clinical sciences
Melanoma: Clinical sciences
Necrotizing soft tissue infections: Clinical sciences
Pressure-induced skin and soft tissue injury: Clinical sciences
Approach to lymphoma: Clinical sciences
Approach to hallucinogen, inhalant, and cannabis use, intoxication, and overdose: Clinical sciences
Approach to stimulant use, intoxication, and overdose: Clinical sciences
Approach to trauma and stressor-related disorders: Clinical sciences
Opioid intoxication and overdose: Clinical sciences
Bipolar I, bipolar II, and cyclothymic disorder: Clinical sciences
Opioid use disorder: Clinical sciences
Substance use disorder: Clinical sciences
Approach to a fever in the returned traveler: Clinical sciences
Approach to a postoperative fever: Clinical sciences
Approach to acid-base disorders: Clinical sciences
Approach to a fever: Clinical sciences
Approach to hypercalcemia: Clinical sciences
Approach to hyperkalemia: Clinical sciences
Approach to hyponatremia: Clinical sciences
Approach to metabolic alkalosis: Clinical sciences
Approach to nosocomial infections: Clinical sciences
Approach to metabolic acidosis: Clinical sciences
Approach to hypernatremia: Clinical sciences
Approach to respiratory acidosis: Clinical sciences
Approach to respiratory alkalosis: Clinical sciences
Infectious mononucleosis: Clinical sciences
Obesity and metabolic syndrome: Clinical sciences
Systemic lupus erythematosus: Clinical sciences
Tuberculosis (extrapulmonary and latent): Clinical sciences
Approach to unsteadiness, gait disturbance, or falls: Clinical sciences
Myasthenia gravis: Clinical sciences
Osteoarthritis: Clinical sciences
Septic arthritis: Clinical sciences
Spinal fractures: Clinical sciences
Rheumatoid arthritis: Clinical sciences
Spinal infection and abscess: Clinical sciences
Approach to aphasia: Clinical sciences
Approach to blunt traumatic cervical spine injuries: Clinical sciences
Approach to differentiating lesions (brainstem): Clinical sciences
Approach to differentiating lesions (cerebral cortical and subcortical structures): Clinical sciences
Approach to differentiating lesions (cerebellum): Clinical sciences
Approach to differentiating lesions (motor neuron): Clinical sciences
Approach to differentiating lesions (nerve root, plexus, and peripheral nerve): Clinical sciences
Approach to differentiating lesions (spinal cord): Clinical sciences
Approach to dysarthria or dysphagia: Clinical sciences
Approach to headache or facial pain: Clinical sciences
Approach to epilepsy: Clinical sciences
Approach to increased intracranial pressure: Clinical sciences
Approach to traumatic brain injury: Clinical sciences
Acute stroke (ischemic or hemorrhagic) or TIA: Clinical sciences
Delirium: Clinical sciences
Brain death: Clinical sciences
Diabetes insipidus: Clinical sciences
Guillain-Barré syndrome: Clinical sciences
Meningitis and brain abscess: Clinical sciences
Subarachnoid hemorrhage: Clinical sciences
Approach to lower limb edema: Clinical sciences
Approach to vasculitis: Clinical sciences
Deep vein thrombosis: Clinical sciences
Venous insufficiency and ulcers: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Approach to vaginal discharge: Clinical sciences
Chlamydia trachomatis infection: Clinical sciences
Neisseria gonorrhoeae infection: Clinical sciences
Pelvic inflammatory disease: Clinical sciences
Approach to dyspnea: Clinical sciences
Approach to pneumoperitoneum and peritonitis (perforated viscus): Clinical sciences
Acute respiratory distress syndrome: Clinical sciences
Asthma in pregnancy: Clinical sciences
Airway obstruction: Clinical sciences
Atelectasis: Clinical sciences
Asthma: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Empyema: Clinical sciences
Hospital-acquired and ventilator-associated pneumonia: Clinical sciences
Influenza: Clinical sciences
Pleural effusion: Clinical sciences
Pulmonary embolism: Clinical sciences
Pneumothorax: Clinical sciences
Upper respiratory tract infections: Clinical sciences
Tuberculosis (pulmonary): Clinical sciences
Approach to acute kidney injury: Clinical sciences
Catheter-associated urinary tract infection: Clinical sciences
Intrinsic acute kidney injury (glomerular causes): Clinical sciences
Chronic kidney disease: Clinical sciences
Intrinsic acute kidney injury (non-glomerular causes): Clinical sciences
Lower urinary tract infection: Clinical sciences
Postrenal acute kidney injury: Clinical sciences
Pyelonephritis: Clinical sciences
Prerenal acute kidney injury: Clinical sciences
Asthma: Information for patients and families (The Primary School)
Food allergies and EpiPens: Information for patients and families (The Primary School)
Empathetic listening for clinicians
Shared decision-making
Implicit bias
The do's and don'ts of patient care
Cardiovascular disease screening: Clinical sciences
Essential hypertension: Clinical sciences
Approach to a murmur (pediatrics): Clinical sciences
Carotid artery stenosis screening: Clinical sciences
Acute rheumatic fever and rheumatic heart disease: Clinical sciences
Randomized control trial
Clinical trials
Study designs
Bias in performing clinical studies
Problem-based learning
Sample size
Information bias
Selection bias
Case-control study
Cohort study
Hypothesis testing: One-tailed and two-tailed tests
Correlation
Paired t-test
Types of data
Bias in interpreting results of clinical studies
Two-sample t-test
The role of the kidney in acid-base balance
Anatomy of the glossopharyngeal nerve (CN IX)
Anticoagulants: Warfarin
Class I antiarrhythmics: Sodium channel blockers
Hepatitis A and Hepatitis E virus
Class IV antiarrhythmics: Calcium channel blockers and others
Anatomy clinical correlates: Oculomotor (CN III), trochlear (CN IV) and abducens (CN VI) nerves
Anatomy of the facial nerve (CN VII)
Anatomy of the vestibulocochlear nerve (CN VIII)
Anatomy clinical correlates: Glossopharyngeal (CN IX), vagus (X), spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy clinical correlates: Facial (CN VII) and vestibulocochlear (CN VIII) nerves
Anatomy of the trigeminal nerve (CN V)
Anatomy of the spinal accessory (CN XI) and hypoglossal (CN XII) nerves
Anatomy of the vagus nerve (CN X)
Definitions of acids and bases
Anatomy clinical correlates: Trigeminal nerve (CN V)
Kidney stones: Pathology review
Meningitis
Cellulitis and erysipelas: Clinical sciences
Sepsis: Clinical sciences
Bacterial vaginosis: Clinical sciences
Aspiration pneumonia and pneumonitis: Clinical sciences
Clostridioides difficile infection: Clinical sciences

Transcript

Watch video only

A group of people who share a common characteristic is called a cohort.

For example, people born in the year 1981 make up a birth cohort, and people who work in construction make up an occupational cohort.

Now, cohort studies or longitudinal studies are a type of study design that follows a cohort of people over time to figure out if there’s an association between an exposure and an outcome.

Typically, cohort studies look at individuals in a cohort who have a certain exposure, as well as individuals in a cohort who have not had that exposure, to compare their rates of a certain outcome in the future.

For example, let’s say we want to figure out if there’s a relationship between smoking cigarettes and developing lung cancer.

To do this, we could follow 100,000 individuals that smoke cigarettes, the exposed group, and 100,000 individuals that don’t smoke cigarettes, the non-exposed group, for ten years.

After ten years, let’s say that 82 of the 100,000 people - 0.082% - who smoked developed lung cancer, and only 3 of the 100,000 people - 0.003% - who didn’t smoke developed lung cancer.

We can then compare the groups by dividing the probability of lung cancer for people who smoked - 0.00082 - by the probability of lung cancer for people who didn’t smoke - 0.00003 - and determine that people that smoked had 27 times the risk of developing lung cancer during that ten period.

As it turns out, smoking is the number one risk factor of most types of lung cancer, and people who smoke are 15 to 30 times more likely to develop lung cancer than people who don’t smoke.

Now, there are two main types of cohort studies.

The first type is called prospective cohort or concurrent cohort, because individuals are followed forward in time.

An example would be if in 2018 a group of smokers and a group of non-smokers are recruited for the study.

Then the two groups are followed for ten years, until 2028, and the number of people who develop lung cancer is compared between the two groups.

Prospective cohort studies are the most common type of cohort study, and are what people usually think of when they hear about a “cohort study”.

The other type of cohort study is a retrospective cohort study, also called historical or non-concurrent cohort study.

In retrospective cohort studies, participants are recruited in the past and then followed until the present day.

This can be done either with time-travel or by simply by looking at medical records from the past.

For example, you might look at medical records to find a cohort of young adults in 2008 and then divide them into a group of people that smoke cigarettes, the exposed group, and a group of people that don’t smoke cigarettes, the non-exposed group.

Then we can follow the medical records of these individuals over the next ten years, until 2018, and compare the number of individuals in each group who develop lung cancer.

So even though retrospective cohort studies use data from the past, they still have the same basic structure as prospective cohort studies.

In other words, they still start with a cohort of exposed and non-exposed individuals and follow them over time to assess their outcomes.

Now, this is different from case-control studies, which start with individuals who do or don’t have the outcome, and then use data to investigate past exposures.

This can get a bit confusing because case-control studies are sometimes called retrospective studies, and cohort studies can be either prospective cohort or retrospective cohort studies.

One advantage of cohort studies is that they’re able to clearly show the timing or temporality of the relationship between the exposure and the outcome.

For example, out of 200 people, 100 that smoke and 100 that don’t smoke, none of them have lung cancer at the beginning of the study.

But after ten years, more individuals that smoke develop lung cancer compared to individuals that don’t smoke, so it’s pretty clear that smoking happened first and lung cancer happened second.

Because of this, cohort studies are usually preferred over other study designs, like cross-sectional studies, which measure the outcome and the exposure at the exact same time.

Key Takeaways

A cohort study is a study that helps to determine a relationship between an exposure and a future outcome. In cohort studies, a group of people with a specific characteristic, such as exposure to a particular substance, are followed over time to see if they develop a specific disease or health outcome.

Cohort studies can be either prospective or retrospective. In prospective cohort studies, also known as concurrent cohort studies, individuals are followed forward in time, and the number of people who develop a particular outcome gets compared between the two groups. Next, we have retrospective cohort studies, also called historical or non-concurrent cohort studies. In retrospective cohort studies, two groups of individuals are selected in the past and followed up until the present day. Comparing two groups determines the number of individuals in each group who develop a particular outcome.